ExploreWatchlistsPricing
  1. JP-listed companies
  2. TOWA PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Pretax margin (%)

TOWA PHARMACEUTICAL CO.,LTD. (4553)

Market cap
¥198.9B
P/E ratio
8.8x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202610.3+1.83%
Mar 31, 202510.1-6.19%
Mar 31, 202410.7+336.27%
Mar 31, 20232.5-82.07%
Mar 31, 202213.7+13.87%
Mar 31, 202112.1-36.59%
Mar 31, 202019+5.94%
Mar 31, 201917.9+43.12%
Mar 31, 201812.5+43.63%
Mar 31, 20178.7-29.41%
Mar 31, 201612.4-42.73%
Mar 31, 201521.6+50.00%
Mar 31, 201414.4-16.66%
Mar 31, 201317.3-14.47%
Mar 31, 201220.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat